You are here:

Home
NICE Guidance
Conditions and diseases
Skin conditions
Diabetic foot

Granulox for managing chronic non-healing wounds

Medtech innovation briefing
Reference number: MIB296
Published: 10 May 2022

Download (PDF)

Overview
Summary
The technology
Regulatory information
Equality considerations
Clinical and technical evidence
Expert comments
Patient organisation comments
Expert commentators
Development of this briefing

Regulatory information

Granulox is a CE-marked class III medical device.

Next page Equality considerations Previous page The technology